QualityStocksNewsBreaks Archives - Page 1145 of 1605

FridayMar 13, 2020 9:39 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Financial Results for Q4, Full Year 2019

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, on Thursday announced financial results for the fourth quarter and full year 2019. According to the update, Foresight ended the fourth quarter of 2019 with $10.1 million in cash and short-term deposits. The company reported GAAP net loss of $4.37 million and non-GAAP net loss of $4 million for the fourth quarter of 2019. “Foresight completed 2019 with a series of positive developments, as our QuadSight(R) vision system continued to gain commercial interest as well as award recognition,” Foresight’s CEO Haim Siboni said in the news release.…

FridayMar 13, 2020 9:30 am

QualityStocksNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Provides Update on Technology Licensing Agreement, Reports Changes to Executive Team

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), an integrated oil ‎company focused on the development and implementation of its proprietary oil-‎extraction and remediation technologies, on Thursday provided an update regarding progress on the licensing of its proprietary oil-sands extraction ‎technology. In July 2019, the company entered into a non-exclusive technology licensing agreement with Valkor LLC granting Valkor the right to use Petroteq’s proprietary patented technology to engineer, construct, operate and finance oil sands extraction plants. Per the agreement, Valkor would pay the company a non-refundable license fee of US$2 million per plant in two equal payments, the first of which being…

ThursdayMar 12, 2020 11:30 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Launch of New AI Platform for Vaccine and Drug Development Targeting COVID-19, MERS and SARS

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its plans to launch a new AI platform for vaccine and drug development targeting Coronaviruses and Acute Respiratory Syndromes (COVID-19, MERS and SARS) through an operating agreement with Soluble Therapeutics. According to the update, POAI has also signed a letter of intent with InventaBioTech to acquire Soluble Therapeutics, its assets and its HSCTM Technology. As global health experts predict an ever-increasing number of viral outbreaks like COVID-19, POAI is taking proactive measures to be part of the solution by…

ThursdayMar 12, 2020 10:35 am

QualityStocksNewsBreaks – Sugarmade, Inc.’s (SGMD) BudCars Sees Sharp Rise in Delivery Demand as Coronavirus Impacts Cannabis Consumer Patterns

Sugarmade (OTCQB: SGMD), together with the BudCars Cannabis Delivery Service, today announced a sharp rise in demand for its cannabis delivery service, driving an associated 10% week-over-week rise in total sales over the past two weeks. According to the update, the company believes this dynamic is being driven by the stay-at-home trend that has emerged in many communities around the world in response to the global COVID-19 outbreak. “The Coronavirus pandemic is undeniably a game-changer for consumer behavior patterns that will likely have long-term implications as it drives new habits into place,” Sugarmade CEO Jimmy Chan, who recently announced a…

ThursdayMar 12, 2020 10:30 am

QualityStocksNewsBreaks – Youngevity International, Inc. (NASDAQ: YGYI) Exploring Divestiture of Direct Selling Business Unit to Original Founders

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and a commercial hemp enterprise, today announced that it is exploring the divestiture of its direct selling business unit back to the original founders of the direct selling division. According to the update, YGYI has entered into a non-binding term sheet regarding a potential transaction with Steve and Michelle Wallach, and its board of directors has formed a special committee consisting of all of its independent directors to review and consider the terms of the proposed transaction. An investment banking…

ThursdayMar 12, 2020 9:42 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Receives Order for Game-Changing UST System from Can B Corp. (CANBD)

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer, Can B Corp. (OTCQB: CANBD). According to the update, the order is for one of PBIO’s proprietary BaroShear K45 Ultra Shear Technology(TM) ("UST")-based systems for processing CBD oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. The nanoemulsions are expected to exhibit bioavailability levels that far exceed the absorption efficiency of today's macro or microemulsions of…

ThursdayMar 12, 2020 9:29 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Obtains C$80.5M Debt Financing Arrangement with Canopy Growth Corp. (TSX: WEED) (NYSE: CGC)

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Wednesday announced that TerrAscend Canada Inc., a wholly owned subsidiary of CNPOF’s portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), has entered into an C$80.5 million loan financing arrangement with Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) pursuant to a secured debenture. TerrAscend has issued 17,808,975 common share purchase warrants to Canopy Growth in connection with the loan. TerrAscend Canada intends to use the net proceeds toward general corporate purposes, the funding of its Canadian operations, its Arise Bioscience U.S. hemp division, international expansion, and the…

WednesdayMar 11, 2020 1:26 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Trading Volume Rapidly Surged During First Four Days of Trading

InsuraGuest Technologies (TSX.V: ISGI) is a SaaS (Software-as-a-Service) company and the developer of the proprietary InsurTech platform designed to deliver insurance products to the hotel and vacation-rental market. On Friday, February 28 the company’s common shares began trading on the TSX Venture Exchange (“TSX.V”) under the symbol “ISGI”. According to an article on the company’s website titled ‘InsuraGuest Technologies Inc. Goes Public, Sees Trading Volume and Price Rise’, ISGI opened with a trading volume of 2,000 shares at $0.40 each. The price declined slightly before quickly climbing again, as the trading volume surged substantially to over 200,000 shares throughout the…

WednesdayMar 11, 2020 10:56 am

QualityStocksNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Secures US Patent for “Interactive System Based on Light Intensity Recognition”

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced the United States Patent and Trademark Office’s issuance of U.S. patent number US 10,512,836 B2, covering Blue Hat's “Interactive System Based on Light Intensity Recognition.” According to the update, the Blue Hat system connects a physical toy with the virtual content of a mobile game, which the Company believes represents a major breakthrough in the realization of AR technology. Blue Hat's AR Racer product is a prominent example of the potential presented by…

WednesdayMar 11, 2020 10:51 am

QualityStocksNewsBreaks – MCTC Holdings, Inc. (MCTC) Begins Organization of Animal Study Focused on THC-V and Appetite Suppression, Weight Loss

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, seeks to answer a pressing question within the cannabinoid industry arena: Does tetrahydrocannabivarin (“THC-V”) promote weight loss? According to the update, MCTC has completed Phase One of its Project Varin, a program designed to develop delivery systems and uses for THC-V, and is moving into its second phase of research. Company researchers are now organizing what is believed to be the industry's first animal study specifically focused on determining if the administration of THC-V leads to appetite suppression and/or weight loss. “While many…

Site Search

Company Search

Category: QualityStocksNewsBreaks